BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

406 related articles for article (PubMed ID: 17636427)

  • 1. Hereditary gynecologic cancers: differential diagnosis, surveillance, management and surgical prophylaxis.
    Lu KH
    Fam Cancer; 2008; 7(1):53-8. PubMed ID: 17636427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Society of Gynecologic Oncologists Education Committee statement on risk assessment for inherited gynecologic cancer predispositions.
    Lancaster JM; Powell CB; Kauff ND; Cass I; Chen LM; Lu KH; Mutch DG; Berchuck A; Karlan BY; Herzog TJ;
    Gynecol Oncol; 2007 Nov; 107(2):159-62. PubMed ID: 17950381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hereditary gynecologic cancers.
    Mutch D; Denny L; Quinn M;
    Int J Gynaecol Obstet; 2014 Mar; 124(3):189-92. PubMed ID: 24429354
    [No Abstract]   [Full Text] [Related]  

  • 4. Hereditary breast and ovarian cancer (HBOC): clinical features and counseling for BRCA1 and BRCA2, Lynch syndrome, Cowden syndrome, and Li-Fraumeni syndrome.
    Shulman LP
    Obstet Gynecol Clin North Am; 2010 Mar; 37(1):109-33, Table of Contents. PubMed ID: 20494261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gynecologic cancer as a "sentinel cancer" for women with hereditary nonpolyposis colorectal cancer syndrome.
    Lu KH; Dinh M; Kohlmann W; Watson P; Green J; Syngal S; Bandipalliam P; Chen LM; Allen B; Conrad P; Terdiman J; Sun C; Daniels M; Burke T; Gershenson DM; Lynch H; Lynch P; Broaddus RR
    Obstet Gynecol; 2005 Mar; 105(3):569-74. PubMed ID: 15738026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic testing by cancer site: ovary.
    Weissman SM; Weiss SM; Newlin AC
    Cancer J; 2012; 18(4):320-7. PubMed ID: 22846732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hereditary non-BRCA gynecological tumors.
    Vellone VG; Paudice M; Varesco L
    Minerva Ginecol; 2016 Oct; 68(5):579-86. PubMed ID: 26930387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hereditary cancer-associated mutations in women diagnosed with two primary cancers: an opportunity to identify hereditary cancer syndromes after the first cancer diagnosis.
    Saam J; Moyes K; Landon M; Williams K; Kaldate RR; Arnell C; Wenstrup R
    Oncology; 2015; 88(4):226-33. PubMed ID: 25503195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gynecologic manifestations of hereditary nonpolyposis colorectal cancer. From inherited to sporadic disease.
    Taylor N; Mutch DG
    Oncology (Williston Park); 2006 Jan; 20(1):85-94; discussion 94-6, 100. PubMed ID: 16572595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hereditary breast-ovarian cancer: clinical findings and medical management.
    Marshall M; Solomon S
    Plast Surg Nurs; 2007; 27(3):124-7. PubMed ID: 17901820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prophylactic surgery of mammary and ovarian carcinoma].
    Lux MP; Bani MR; Fasching PA; Beckmann MW
    Chirurg; 2005 Dec; 76(12):1145-54. PubMed ID: 16237564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SEOM clinical guidelines for hereditary cancer.
    GraƱa B; Lastra E; Llort G; Brunet J; Isla D
    Clin Transl Oncol; 2011 Aug; 13(8):580-6. PubMed ID: 21821494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endometrial cancers in mutation carriers from hereditary breast ovarian cancer syndrome kindreds: report from the Creighton University Hereditary Cancer Registry with review of the implications.
    Casey MJ; Bewtra C; Lynch HT; Snyder CL; Stacey M
    Int J Gynecol Cancer; 2015 May; 25(4):650-6. PubMed ID: 25756400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigating barriers to genetic counseling and germline mutation testing in women with suspected hereditary breast and ovarian cancer syndrome and Lynch syndrome.
    Shaw J; Bulsara C; Cohen PA; Gryta M; Nichols CB; Schofield L; O'Sullivan S; Pachter N; Hardcastle SJ
    Patient Educ Couns; 2018 May; 101(5):938-944. PubMed ID: 29273311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hereditary diffuse gastric cancer and lynch syndromes in a BRCA1/2 negative breast cancer patient.
    Njoroge SW; Burgess KR; Cobleigh MA; Alnajar HH; Gattuso P; Usha L
    Breast Cancer Res Treat; 2017 Nov; 166(1):315-319. PubMed ID: 28702897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening and prevention of hereditary gynecologic cancers.
    Kehoe SM; Kauff ND
    Semin Oncol; 2007 Oct; 34(5):406-10. PubMed ID: 17920895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hereditary risk of women's cancers.
    Frank TS; Critchfield GC
    Best Pract Res Clin Obstet Gynaecol; 2002 Oct; 16(5):703-13. PubMed ID: 12475549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Lynch syndrome and gynaecologic's cancer: follow-up recommendations].
    Magri K; Millon G
    J Gynecol Obstet Biol Reprod (Paris); 2007 Feb; 36(1):68-71. PubMed ID: 17293255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hereditary gynaecological malignancies: advances in screening and treatment.
    Folkins AK; Longacre TA
    Histopathology; 2013 Jan; 62(1):2-30. PubMed ID: 23240667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Recommendations for the management of women with an increased genetic risk of gynaecological cancer].
    Verheijen RH; Boonstra H; Menko FH; de Graaff J; Vasen HF; Kenter GG
    Ned Tijdschr Geneeskd; 2002 Dec; 146(50):2414-8. PubMed ID: 12518519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.